Pharmerica Is One Of Three Pharmacies Selected By Teva Pharmaceuticals To Dispense AUSTEDO™, A Medication For Huntington’s Disease & Tardive Dyskinesia.
As Huntington’s disease progresses and symptoms increase, many residents will require more care, and PharMerica can help. PharMerica is one of only three pharmacies to dispense AUSTEDO™, a medication for treatment of chorea associated with Huntington’s disease.
AUSTEDO™ has been clinically shown to decrease the Total Maximal Chorea Score in patients by 4.4 points based on the Unified Huntington’s Disease Rating Scale (UHDRS).
AUSTEDO™ has a Black Box Warning for DEPRESSION AND SUICIDALITY, for increasing the risk of depression and suicidal thoughts and behavior. Balance risks of depression and suicidality with the clinical need for treatment of chorea when considering the use of AUSTEDO™.
About Tardive Dyskinesia
Tardive dyskinesia (TD) is a disorder that involves involuntary movements. The movements most often affect the lower face. Tardive means delayed, and dyskinesia means abnormal movement.
About Huntington’s Disease
Huntington’s disease is a progressive brain disorder that causes uncontrolled movements, emotional problems, and loss of thinking ability (cognition).
If your facility is presently treating any resident diagnosed with Huntington’s Disease or Tardive Dyskinesia and their attending physician desires to prescribe them AUSTEDO™, PharMerica is ready to assist your facility in securing this medication for your resident. We look forward to helping you.
To order an AUSTEDO™ prescription please contact PharMerica
by phone at 1-800-678-7575 press option #3, or fax at 1-844-602-0231.